Do you have the passion to join a group whose mission is to pioneer the discovery of a new class of medicines to treat diseases unaddressed by today’s therapies? Does it excite you to be a part of a company with a focus on cancer and genetically-validated targets in other disease areas with unmet medical need? If yes, you may be a great fit to join Arrakis on our path to bring powerful new therapies to millions of patients.
Your Impact at Arrakis:
The mission of Arrakis Therapeutics is to extend small molecule medicines into new realms of biology by discovering and developing compounds that selectively target RNA (“rSM”). By targeting distinct RNA structure/function relationships, Arrakis is generating drug candidates with novel mechanisms of action for molecular targets that are challenging to drug in disease areas with high unmet medical need.
Arrakis uses next-generation sequencing (NGS) assays to power our platform for identifying druggable RNA structures. The Associate Scientist will have an opportunity to make an impact on the nascent field of rSM discovery by developing and applying world-class NGS methods to elucidate RNA structure features inside living cells and in vitro. This individual will work as part of a team to integrate these structural analyses with functional analyses and high-resolution structural biology experiments to support our drug discovery process. The ideal candidate will enjoy working in a collaborative, fast-paced start-up environment, leveraging a high degree of integrity, intelligence and innovation to make a large impact on our mission.
Interested in learning more about Arrakis? Click on the links below!
Arrakis is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, religion, national origin or ancestry, sex, pregnancy, sexual orientation, gender identity, age, disability, military service, veteran status, genetic information, or any other characteristic protected by law.
Your application was submitted successfully.